The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.

IPO drought, the industry is questioning whether the window for medtech public offerings is open following a small burst of ...

The Court of International Trade said the president overstepped his authority, halting various duties. After an appeal, the ...

The maker of patient monitoring devices said the incident will not have a material effect on its updated financial outlook.

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory ...

The company will compete with a device Boston Scientific acquired for $850 million.

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position ...

The duties are slated to take effect July 9 as the bloc and the U.S. reengage on trade talks, the president said.

The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

A problem when preparing the devices for use can delay diagnosis or treatment, leading BD to update its instructions.